About ferric carboxyma ltose
Intravenous iron replacement
Used for
- Treats iron-deficiency anaemia when oral iron is unsuitable or ineffective.
- Replenishes iron stores in certain people with chronic kidney disease or heart failure.
Usual adult dose
Given intravenously; dose is calculated from body weight and iron deficit, usually in one or more doses.
Usual dose in children
For children aged 1 year and older: dose is calculated from body weight and iron deficit; given intravenously.
Common side effects
- Nausea, headache, dizziness, or flushing
- Injection-site reactions or high blood pressure
- Low blood phosphate, sometimes with repeated treatment
- Rare severe allergic reactions
Important warnings
- Must be administered where severe allergic reactions can be treated.
- Monitor during administration and for at least 30 minutes afterwards.
- Check iron status and avoid iron overload.
- Repeated or prolonged use can cause low phosphate and bone problems.
Pregnancy
Use only when clearly necessary; usually avoid during the first trimester. Intravenous iron may be considered later if needed.
Breastfeeding
Small amounts may enter breast milk; available information suggests use is generally compatible with breastfeeding.
Interactions
- May reduce absorption of oral iron; avoid oral iron for at least five days afterwards.
AI-generated from general medical knowledge, not from this product's official leaflet. It may be incomplete or out of date. Not medical advice — ask a pharmacist or doctor before making any decision.